Carregant...
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification
BACKGROUND: Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter...
Guardat en:
| Publicat a: | J Neurointerv Surg |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629931/ https://ncbi.nlm.nih.gov/pubmed/27799376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2016-012612 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|